A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

Phase 1 Not yet recruiting 44 enrolled Addpharma Inc.

RandomizedCrossoverOpen-labelTreatment

Summary

The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers

Timeline

Start: 2025-12
Primary completion: 2026-01
Completion: 2026-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AD-116	Unknown	—	Oral
Subject	AD-1161	Unknown	—	Oral

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

Summary

Timeline

Drugs

Indications